Physician profile
John J Park
NPI 1992750020
$14,345.13
in general payments reported to CMS, 2019-2025
25 companies · $746 in 2025
The $746 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,523 · 2020: $4,149 · 2021: $2,635 · 2022: $1,294 · 2023: $908 · 2024: $2,090 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,438 · Travel and Lodging: $1,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,437.87 |
| Travel and Lodging | $1,306.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $3,224.34 | 2020-2022 | |
| Axonics, INC. | $2,902.81 | 2020-2024 | Axonics, Bulkamid |
| Medtronic USA, INC. | $2,001.67 | 2019-2020 | |
| Applied Medical Resources Corporation | $1,069.32 | 2019 | |
| Davol INC. | $843.48 | 2019-2025 | Phasix Mesh |
| Stryker Corporation | $685.57 | 2019 | |
| Medtronic, INC. | $668.16 | 2021-2025 | Signia, Ligasure, Interstim |
| Intuitive Surgical, INC. | $653.60 | 2019-2024 | |
| Ethicon US, LLC | $644.91 | 2021-2025 | Echelon Flex, Echelon Circular, Contour |
| Conmed Corporation | $254.76 | 2019-2022 | |
| Allergan, INC. | $247.44 | 2021 | |
| Boston Scientific Corporation | $195.11 | 2025 | Axonics, General - Female Sui |
| Covidien LP | $176.20 | 2019 | |
| Guard Medical INC. | $156.43 | 2023 | Npseal Large, Npseal Medium, Npseal (5) |
| Innovation Technologies INC | $101.94 | 2019-2023 | Irrisept |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $101.31 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $91.96 | 2019-2023 | Exparel |
| Braintree Laboratories, INC. | $91.54 | 2021-2023 | Suflave, Sutab |
| Solventum Corporation | $85.70 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Alfasigma USA, INC. | $33.60 | 2021-2022 | |
| Tempus Ai, INC | $30.00 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $29.82 | 2025 | |
| Exact Sciences Corporation | $19.71 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.34 | 2024 | Plenvu, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $17.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.